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In this issue of the Journal, Stack et al. (I I describe a cohorI 
of 342 patients with evolving myocardial iniarcdon treated 
wilh emergsncy coronary angioplasty. With complete I year 
follow-up d&a. the out 01 hospital monalily raw of 2.6% 
canmares favorablv with the 7.2% rate in the lanze sale 
G&m Italiano per IO SIudia della Slreptochinos~nell’In- 
farcto KiISSIl trial for patients receiving intravenous strep 
tokinnse (2). and Ibe 9 IO if% fat&y rate in other recent 
observational studies (3.4) that mwdared rcpcrfusion thcr- 
apy. Similarly. the 3% incidence rate of reinfarcdon during 
f~dlow-up is subslantially lower than the 6 to &!& rate 
previously refxmed with or wilhoul thrombolytic therapy 
(56). 
ChamcterisIia of Ibe Duke &. Although these find- 
ings arc imponanl and encour&g, they need to be placed 
in context. The Duke series lacks a conlrol group and 
represents a select PIUU~ of patients referred to a regional 
center who received a &chic Iherapy: emergrncy car& 
antioplastv. In addition to aneioolastv. lhmmbnlvtic tberasv 
was admi&lered to 95% ofihe’p&nts. an int&sive I&- 
ical regmen was prescribed consisting of adminiswalian of 
calcium Goand blocking agents. b:ta-adrenergic blocking 
agents and aspirin, and 14% patients underwent coronary 
artery bypass surgery in the hospital. Although this group 
war certainly highly selected and received considerably 
nwe than emergency coronary angioplasty. the inclusion of 
13% of patients with cardiogenic shock represents a consid- 
erably higher proportion of gravely ill patients than that 
found in recent reprfusion studies (2.7.8). Funhermore. the 
finding of a very low out of hospiml monality rate .aRer 
myocardi?l inf?cIion has also recemly been corr&wated by 
two other multicenter studies 17.81 in which palienls re- 
cei*:-,: thrumbolytic therapy arad the majorily undement 
coronary angioplady. 
FncIora kndlng IO pnleadnl hntntl of cmer#mcy CotoMry 
mgbpla+Iy. If borne out. the long-term bemflts of coronary 
angioplasly may be derived from several faclors. Firsl. 
lhrombolylic Ihempy in itself leads lo an increav in recur- 
rent isch&ic eve& compared wilh those that follow con- 
ventional or placebo therapy (2.5,9.10). When it follows 
Ihrombnlylic therapy in the hospital phase, camnary angio- 
plasly has been shown to reduce such events (7,11.12) and 
most likely this bcnefil will be amplified over the duration of 
follow-up: Second. by mechanics ncanalization of infarct- 
related vessels resislant LO thmmbidvlic fhenwv. immediate 
comnary angioplasty may maxi& the pm&ion of pa- 
tients with an Ywen” infarct vcsscl. Indeed. Stack et al. (II 
had aucceaoful r&malization in 94% of peticnb with cam- 
bined Ihmmbolysis and immediate angiopl~~y. Thii, BE- 
cording to the data from the Western Washington intrzar& 
nary streptakinax trial ll3), patitnts with a wklely patent 
infarct vessel had the highest likelihood cf lang-term sur- 
Gal, even thwgk impmvement of ventriculw fimclion was 
no1 demonalraled. The potential advan~~y, of a swained 
open vessel include: I) a higher threshold for ventricular 
tachyarrbytbmias (14.15). 2) improved healing of the infarct 
zone with less venlricular amurysm f-lion or cardiac 
dilation M-10, and 3) preservsIion of an epicardial conduit 
for fulure collaIeral hlocd supply. In the Duke wies. Ihc 
92% patency raIe of the i&rcI vessel befar discharge 
provided optimal ammrwnitv for such clinical bcnefds IO be 
bernonsI&d in f&w-up. _ 
Tkc%diem~‘~. Withallofthesepolenlial 
benefits of coronary angioplnsty for acute myacardial infare- 
Iion. why has the “hallwn leaking” cowpI been raised? 
(191. In Ihe recenl angioplas~y trials (I2.20.2I) focusing on 
oulcome during Ihe short lerm of hospital slay. immediate 
coronary angiaplasty did no1 improve venbicular fun&n at 
rest or reduce mortality. Recendy. Guerci et al. (22) dem. 
onstraled imorovemenl of ventricular fun&m dnrinr ever- 
cise for pa&r in whom coronary angioplasty &s per- 
formed 3 days tier thrombolydc therapy. An&et key 
factor relates to the liming of coronary angioplasty. From 
the three randomized trials of immediate a@plasly com- 
pared with a delayed strategy, if ir clear lhal an &dive 
approach is generally preferable and that ventricular func- 
lion was not compromised by deferring angioplasty (12.20. 
20. However. unlike the Duke consecutive setis in which 
angioplasly was performed immediately after rtnptokinasc 
infusion in 78% of p:aliems. these trials tcsld the appropri- 
ale lirrdng of inlervenlion after lissue plasminogen r&valor 
infusion. Al I& lime of angioplasry. only 4CPZ of patients in 
the Duke series had a patent infarcl vessel ( I l compared with 
s7G% in Ihe immediate sngiaplasty trials (12.20.?11 41. 
though more practical from a penpectivr or rewource avail- 
ability. the deferral of cardiac catheterization and angia- 
plasly until I LO 14 days after tbrnmholvtic rbemcv obviates 
timely mechanical intervention as a fallback &iurion 
method. With nonclot-selective fibrinolylic agents or cambi- 
nation thromboiytic therapy. the ?Qecific thenpeu!x apple- 
cation of immediate coronary angioplasty for patients rew 
lant lo lylic lhempy has been suggested (/.?3,?4l. Before the 
practice of emrrgotcy coronary angiopia~ty can be aban- 
doned. funher prospective evaluation wing akernative phar- 
maco~ogic approaches will be necessw. 
plients with highest risk of manality m follow-up iere-the 
same patients who could derive tbc most benefit Imm 
aegessive therapy. including patienrc with cardiogenic 
shack. elderly patients and those with impaired ventricular 
hmnclion (2%. Although emergency coronary anpinplasly led 
lo a decrease in apparent mortality m these high risk 
subgroups compared with that in historical control subjects. 
it is premature to conclude that the nskibenefit ratio hi 
been defined. Indeed. it remains possible that emergency 
coronary angioplasty led to an xcelerated timing uimonal- 
ily. giving the false impression of an extremely high out of 
hospital survival rate. In elderly patients. for example. 
coronary angiqdasty for acute myocardial infarction has 
been aswcialed with a high complication rate 126 
Iq*raba. Finally, it is clear that myocardial rewrfw 
aion therapy has changed the natural history for &riemr 
with evolving infarction. Thmmbolytic therapy as a sin& 
intervention leads 10 improved Ion&m &&al I!). The 
polcntial additive impacl of coronary angioplasty for de- 
creaing mortality and reinfarctior is logical and has been 
suggested by Ihe Duke experience. For the various reasons 
enumerated. coronary angiuplasty may emerge ac an impor- 
tant secondary preventive therapy. Clearly. its optimal uli- 
Iii&m will fall somewhere between the 0.3% ue in the 
GISSI follow-up (?I and IOM in the Duke series (11. With 
the appmpriatc use of coronary angioplarly in this setting. 
WC are likely lo realize the imQalani long-lers gain of 
infarct-free survival. 

